264 related articles for article (PubMed ID: 32574901)
1. Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.
Baran M; Grimes KD; Sibbald PA; Fu P; Boshoff HIM; Wilson DJ; Aldrich CC
Eur J Med Chem; 2020 Sep; 201():112408. PubMed ID: 32574901
[TBL] [Abstract][Full Text] [Related]
2. Adenylating enzymes in Mycobacterium tuberculosis as drug targets.
Duckworth BP; Nelson KM; Aldrich CC
Curr Top Med Chem; 2012; 12(7):766-96. PubMed ID: 22283817
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the development of potential inhibitors targeting FadD23 from Mycobacterium tuberculosis.
Yan M; Ma M; Chen R; Cao Y; Zhang W; Liu X
Acta Crystallogr F Struct Biol Commun; 2023 Aug; 79(Pt 8):208-216. PubMed ID: 37522751
[TBL] [Abstract][Full Text] [Related]
4. Fatty acyl-AMP ligases and polyketide synthases are unique enzymes of lipid biosynthetic machinery in Mycobacterium tuberculosis.
Mohanty D; Sankaranarayanan R; Gokhale RS
Tuberculosis (Edinb); 2011 Sep; 91(5):448-55. PubMed ID: 21601529
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic and functional insights into fatty acid activation in Mycobacterium tuberculosis.
Arora P; Goyal A; Natarajan VT; Rajakumara E; Verma P; Gupta R; Yousuf M; Trivedi OA; Mohanty D; Tyagi A; Sankaranarayanan R; Gokhale RS
Nat Chem Biol; 2009 Mar; 5(3):166-73. PubMed ID: 19182784
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
Engelhart CA; Aldrich CC
J Org Chem; 2013 Aug; 78(15):7470-81. PubMed ID: 23805993
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the functional divergence of fatty acyl-AMP ligase biosynthetic enzymes of Mycobacterium tuberculosis.
Goyal A; Verma P; Anandhakrishnan M; Gokhale RS; Sankaranarayanan R
J Mol Biol; 2012 Feb; 416(2):221-38. PubMed ID: 22206988
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.
Neres J; Labello NP; Somu RV; Boshoff HI; Wilson DJ; Vannada J; Chen L; Barry CE; Bennett EM; Aldrich CC
J Med Chem; 2008 Sep; 51(17):5349-70. PubMed ID: 18690677
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis.
Gupte A; Boshoff HI; Wilson DJ; Neres J; Labello NP; Somu RV; Xing C; Barry CE; Aldrich CC
J Med Chem; 2008 Dec; 51(23):7495-507. PubMed ID: 19053762
[TBL] [Abstract][Full Text] [Related]
10. MoS
Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
[TBL] [Abstract][Full Text] [Related]
11. Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis.
Duckworth BP; Geders TW; Tiwari D; Boshoff HI; Sibbald PA; Barry CE; Schnappinger D; Finzel BC; Aldrich CC
Chem Biol; 2011 Nov; 18(11):1432-41. PubMed ID: 22118677
[TBL] [Abstract][Full Text] [Related]
12. 5'-O-[(N-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA: an adenylation enzyme required for siderophore biosynthesis of the mycobactins.
Qiao C; Gupte A; Boshoff HI; Wilson DJ; Bennett EM; Somu RV; Barry CE; Aldrich CC
J Med Chem; 2007 Nov; 50(24):6080-94. PubMed ID: 17967002
[TBL] [Abstract][Full Text] [Related]
13. Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents.
Bythrow GV; Mohandas P; Guney T; Standke LC; Germain GA; Lu X; Ji C; Levendosky K; Chavadi SS; Tan DS; Quadri LEN
Biochemistry; 2019 Feb; 58(6):833-847. PubMed ID: 30582694
[TBL] [Abstract][Full Text] [Related]
14. Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosis.
Duckworth BP; Wilson DJ; Nelson KM; Boshoff HI; Barry CE; Aldrich CC
ACS Chem Biol; 2012 Oct; 7(10):1653-8. PubMed ID: 22796950
[TBL] [Abstract][Full Text] [Related]
15. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
16. A universal pocket in fatty acyl-AMP ligases ensures redirection of fatty acid pool away from coenzyme A-based activation.
Patil GS; Kinatukara P; Mondal S; Shambhavi S; Patel KD; Pramanik S; Dubey N; Narasimhan S; Madduri MK; Pal B; Gokhale RS; Sankaranarayanan R
Elife; 2021 Sep; 10():. PubMed ID: 34490847
[TBL] [Abstract][Full Text] [Related]
17. 1,3-Oxazine-2-one derived dual-targeted molecules against replicating and non-replicating forms of Mycobacterium tuberculosis.
Velappan AB; Kesamsetty D; Datta D; Ma R; Hari N; Franzblau SG; Debnath J
Eur J Med Chem; 2020 Dec; 208():112835. PubMed ID: 32977201
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
[TBL] [Abstract][Full Text] [Related]
19. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
[TBL] [Abstract][Full Text] [Related]
20. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
